Company intelligence / Profile preview

2Morrow

Kirkland, Washington, United States2morrowinc.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company offers a clinically-tested digital platform for behavior change targeting smoking cessation, weight management, and stress. The approach is based on Acceptance and Commitment Therapy developed with Fred Hutchinson Cancer Research Center. Programs are distributed via payers and providers to reduce healthcare costs related to chronic disease. Early clinical results show higher engagement rates compared to traditional coaching methods[3].

Therapeutic areas: PsychiatryEndocrinologyNeurology
Modalities: Non-pharmacological therapy (Digital therapeutics/app-based behavioral intervention)
Industry: Digital Health Medical Devices

Partnerships

Fred Hutchinson Cancer Research Center (scientific collaboration)

Beyond the preview

Go deeper on 2Morrow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2Morrow.

Explore the full profile